In Model 1, apo-CIII1 was associated with a decreased prevalence of retinopathy (β = −7.215, 95% CI −11.137 to −3.294), while apo-CIII2 was associated with an increased prevalence (β = 5.309, 95% CI 2.279 to 8.339). Here, AOPEP is linked to retinal disorder.